ParkinsonCanadaV1, Main, Exploration, bibRecord, 004E80

Dopamine D2 receptor density remains constant in treated Parkinson's disease

Identifieur interne : 004E80 ( Main/Exploration ); précédent : 004E79; suivant : 004E81

Dopamine D2 receptor density remains constant in treated Parkinson's disease

Auteurs : Mark Guttman [Canada] ; Mark Seeman [Canada] ; Gavin P. Reynolds ; Peter Riederer [Autriche] ; Kurt Jellinger [Autriche] ; Wallace W. Tourtellotte

Source :

Annals of Neurology [ 0364-5134 ] ; 1986-05.

RBID : ISTEX:D401455914CA1C7B42C3C05CA253D6D47BA6F19A

Abstract

D2 dopamine receptor densities were measured in postmortem samples of the caudate nucleus and putamen from 36 parkinsonian patients. The relationship between the age of the patient, duration of the disease, and duration of L‐dopa therapy versus density of brain D2 dopamine receptors was examined using [3H]spiperone. Receptor density in parkinsonian tissues was constant over the age range of 56 to 90 years, as was the case for control tissues. Density did not change with duration of disease up to 24 years. Treatment with L‐dopa did not cause progressive reduction in receptor density. The diminished clinical response in the final stages of Parkinson's disease is not due to receptor dropout, and must depend on other factors.

Url:

https://api-v5.istex.fr/document/D401455914CA1C7B42C3C05CA253D6D47BA6F19A/fulltext/pdf

DOI: 10.1002/ana.410190510

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: 000496
to stream Istex, to step Curation: 000496
to stream Istex, to step Checkpoint: 002473
to stream Main, to step Merge: 005886
to stream Main, to step Curation: 004E80

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dopamine D2 receptor density remains constant in treated Parkinson's disease</title>
<author><name sortKey="Guttman, Mark" sort="Guttman, Mark" uniqKey="Guttman M" first="Mark" last="Guttman">Mark Guttman</name>
</author>
<author><name sortKey="Seeman, Mark" sort="Seeman, Mark" uniqKey="Seeman M" first="Mark" last="Seeman">Mark Seeman</name>
</author>
<author><name sortKey="Reynolds, Gavin P" sort="Reynolds, Gavin P" uniqKey="Reynolds G" first="Gavin P." last="Reynolds">Gavin P. Reynolds</name>
</author>
<author><name sortKey="Riederer, Peter" sort="Riederer, Peter" uniqKey="Riederer P" first="Peter" last="Riederer">Peter Riederer</name>
</author>
<author><name sortKey="Jellinger, Kurt" sort="Jellinger, Kurt" uniqKey="Jellinger K" first="Kurt" last="Jellinger">Kurt Jellinger</name>
</author>
<author><name sortKey="Tourtellotte, Wallace W" sort="Tourtellotte, Wallace W" uniqKey="Tourtellotte W" first="Wallace W." last="Tourtellotte">Wallace W. Tourtellotte</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:D401455914CA1C7B42C3C05CA253D6D47BA6F19A</idno>
<date when="1986" year="1986">1986</date>
<idno type="doi">10.1002/ana.410190510</idno>
<idno type="url">https://api-v5.istex.fr/document/D401455914CA1C7B42C3C05CA253D6D47BA6F19A/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000496</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000496</idno>
<idno type="wicri:Area/Istex/Curation">000496</idno>
<idno type="wicri:Area/Istex/Checkpoint">002473</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002473</idno>
<idno type="wicri:doubleKey">0364-5134:1986:Guttman M:dopamine:d:receptor</idno>
<idno type="wicri:Area/Main/Merge">005886</idno>
<idno type="wicri:Area/Main/Curation">004E80</idno>
<idno type="wicri:Area/Main/Exploration">004E80</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Dopamine D2 receptor density remains constant in treated Parkinson's disease</title>
<author><name sortKey="Guttman, Mark" sort="Guttman, Mark" uniqKey="Guttman M" first="Mark" last="Guttman">Mark Guttman</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Medicine and Faculty of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Seeman, Mark" sort="Seeman, Mark" uniqKey="Seeman M" first="Mark" last="Seeman">Mark Seeman</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology, Faculty of Medicine, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
<affiliation wicri:level="4"><country>Canada</country>
<wicri:regionArea>Department of Pharmacology, Medical Sciences Building, University of Toronto, Toronto, Ontario</wicri:regionArea>
<orgName type="university">Université de Toronto</orgName>
<placeName><settlement type="city">Toronto</settlement>
<region type="state">Ontario</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Reynolds, Gavin P" sort="Reynolds, Gavin P" uniqKey="Reynolds G" first="Gavin P." last="Reynolds">Gavin P. Reynolds</name>
<affiliation><wicri:noCountry code="subField">2QQ</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Riederer, Peter" sort="Riederer, Peter" uniqKey="Riederer P" first="Peter" last="Riederer">Peter Riederer</name>
<affiliation wicri:level="3"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Ludwig Boltzmann Institute for Clinical Neurobiology, Lainz Hospital, 1130 Vienna</wicri:regionArea>
<placeName><region type="land" nuts="2">Vienne (Autriche)</region>
<settlement type="city">Vienne (Autriche)</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jellinger, Kurt" sort="Jellinger, Kurt" uniqKey="Jellinger K" first="Kurt" last="Jellinger">Kurt Jellinger</name>
<affiliation wicri:level="3"><country xml:lang="fr">Autriche</country>
<wicri:regionArea>Ludwig Boltzmann Institute for Clinical Neurobiology, Lainz Hospital, 1130 Vienna</wicri:regionArea>
<placeName><region type="land" nuts="2">Vienne (Autriche)</region>
<settlement type="city">Vienne (Autriche)</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tourtellotte, Wallace W" sort="Tourtellotte, Wallace W" uniqKey="Tourtellotte W" first="Wallace W." last="Tourtellotte">Wallace W. Tourtellotte</name>
<affiliation><wicri:noCountry code="subField">90073</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Annals of Neurology</title>
<title level="j" type="sub">Official Journal of the American Neurological Association and the Child Neurology Society</title>
<title level="j" type="abbrev">Ann Neurol.</title>
<idno type="ISSN">0364-5134</idno>
<idno type="eISSN">1531-8249</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1986-05">1986-05</date>
<biblScope unit="volume">19</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="487">487</biblScope>
<biblScope unit="page" to="492">492</biblScope>
</imprint>
<idno type="ISSN">0364-5134</idno>
</series>
<idno type="istex">D401455914CA1C7B42C3C05CA253D6D47BA6F19A</idno>
<idno type="DOI">10.1002/ana.410190510</idno>
<idno type="ArticleID">ANA410190510</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0364-5134</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">D2 dopamine receptor densities were measured in postmortem samples of the caudate nucleus and putamen from 36 parkinsonian patients. The relationship between the age of the patient, duration of the disease, and duration of L‐dopa therapy versus density of brain D2 dopamine receptors was examined using [3H]spiperone. Receptor density in parkinsonian tissues was constant over the age range of 56 to 90 years, as was the case for control tissues. Density did not change with duration of disease up to 24 years. Treatment with L‐dopa did not cause progressive reduction in receptor density. The diminished clinical response in the final stages of Parkinson's disease is not due to receptor dropout, and must depend on other factors.</div>
</front>
</TEI>
<affiliations><list><country><li>Autriche</li>
<li>Canada</li>
</country>
<region><li>Ontario</li>
<li>Vienne (Autriche)</li>
</region>
<settlement><li>Toronto</li>
<li>Vienne (Autriche)</li>
</settlement>
<orgName><li>Université de Toronto</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Reynolds, Gavin P" sort="Reynolds, Gavin P" uniqKey="Reynolds G" first="Gavin P." last="Reynolds">Gavin P. Reynolds</name>
<name sortKey="Tourtellotte, Wallace W" sort="Tourtellotte, Wallace W" uniqKey="Tourtellotte W" first="Wallace W." last="Tourtellotte">Wallace W. Tourtellotte</name>
</noCountry>
<country name="Canada"><region name="Ontario"><name sortKey="Guttman, Mark" sort="Guttman, Mark" uniqKey="Guttman M" first="Mark" last="Guttman">Mark Guttman</name>
</region>
<name sortKey="Seeman, Mark" sort="Seeman, Mark" uniqKey="Seeman M" first="Mark" last="Seeman">Mark Seeman</name>
<name sortKey="Seeman, Mark" sort="Seeman, Mark" uniqKey="Seeman M" first="Mark" last="Seeman">Mark Seeman</name>
</country>
<country name="Autriche"><region name="Vienne (Autriche)"><name sortKey="Riederer, Peter" sort="Riederer, Peter" uniqKey="Riederer P" first="Peter" last="Riederer">Peter Riederer</name>
</region>
<name sortKey="Jellinger, Kurt" sort="Jellinger, Kurt" uniqKey="Jellinger K" first="Kurt" last="Jellinger">Kurt Jellinger</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004E80 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004E80 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:D401455914CA1C7B42C3C05CA253D6D47BA6F19A
   |texte=   Dopamine D2 receptor density remains constant in treated Parkinson's disease
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson au Canada (serveur d'exploration)

Dopamine D2 receptor density remains constant in treated Parkinson's disease

Dopamine D2 receptor density remains constant in treated Parkinson's disease

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri